Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

× No keyword cloud information.

18 in total

1. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.

Authors: Hirohisa Nakamae; Takahisa Yamane; Taro Hasegawa; Mika Nakamae; Yoshiki Terada; Kiyoyuki Hagihara; Kensuke Ohta; Masayuki Hino
Journal: Am J Hematol Date: 2006-07 Impact factor: 10.047

Review 2. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.

Authors: Kenneth R Cooke; Anne Jannin; Vincent Ho
Journal: Biol Blood Marrow Transplant Date: 2008-01 Impact factor: 5.742

Review 3. The role of the endothelium in the short-term complications of hematopoietic SCT.

Authors: E Carreras; M Diaz-Ricart
Journal: Bone Marrow Transplant Date: 2011-04-04 Impact factor: 5.483

4. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial.

Authors: M Attal; F Huguet; H Rubie; A Huynh; J P Charlet; J L Payen; J J Voigt; P Brousset; J Selves; C Muller
Journal: Blood Date: 1992-06-01 Impact factor: 22.113

5. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.

Authors: S Vasu; H Wu; A Satoskar; M Puto; J Roddy; W Blum; R Klisovic; L Andritsos; C Hofmeister; D M Benson; Y Efebera; S Jaglowski; S Penza; D Cohen; S Devine; S Cataland
Journal: Bone Marrow Transplant Date: 2016-04-11 Impact factor: 5.483

Review 6. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

Authors: Vincent T Ho; Corey Cutler; Shelly Carter; Paul Martin; Roberta Adams; Mary Horowitz; James Ferrara; Robert Soiffer; Sergio Giralt
Journal: Biol Blood Marrow Transplant Date: 2005-08 Impact factor: 5.742

7. Tibor Greenwalt Award. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a program for patient care, education and research.

Authors: James N George
Journal: Transfusion Date: 2004-09 Impact factor: 3.157

8. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors: Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal: Chest Date: 2008-06 Impact factor: 9.410

9. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Authors: Sonata Jodele; Christoph Licht; Jens Goebel; Bradley P Dixon; Kejian Zhang; Theru A Sivakumaran; Stella M Davies; Fred G Pluthero; Lily Lu; Benjamin L Laskin
Journal: Blood Date: 2013-06-27 Impact factor: 22.113

10. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors: Sonata Jodele; Tsuyoshi Fukuda; Alexander Vinks; Kana Mizuno; Benjamin L Laskin; Jens Goebel; Bradley P Dixon; Ashley Teusink; Fred G Pluthero; Lily Lu; Christoph Licht; Stella M Davies
Journal: Biol Blood Marrow Transplant Date: 2013-12-25 Impact factor: 5.742

1 in total

1. von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.

Authors: Zhenzhen Xu; Chengwei Luo; Peilong Lai; Wei Ling; Suijing Wu; Xin Huang; Lisi Huang; Guanrong Zhang; Xin Du; Jianyu Weng
Journal: Clin Appl Thromb Hemost Date: 2020 Jan-Dec Impact factor: 2.389

1 in total